Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Oscar Health ( (OSCR) ) is now available.
On June 4, 2025, Oscar Health, Inc. held its 2025 Annual Meeting of Stockholders, where a quorum was established with 825,961,296 votes represented. During the meeting, nine directors were elected, and the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025 was ratified. Additionally, the compensation of the company’s named executive officers was approved on an advisory basis, indicating shareholder support for the company’s leadership and financial oversight.
The most recent analyst rating on (OSCR) stock is a Sell with a $13.50 price target. To see the full list of analyst forecasts on Oscar Health stock, see the OSCR Stock Forecast page.
Spark’s Take on OSCR Stock
According to Spark, TipRanks’ AI Analyst, OSCR is a Outperform.
Oscar Health demonstrates robust financial performance and positive earnings call insights, with significant revenue and membership growth. While technical indicators suggest moderate bullish momentum, the high valuation could pose risks. The company’s commitment to disciplined execution and operational efficiency are key strengths, although regulatory challenges and increased medical loss ratios remain concerns.
To see Spark’s full report on OSCR stock, click here.
More about Oscar Health
Oscar Health, Inc. operates in the health insurance industry, focusing on providing technology-driven health insurance solutions. The company is known for its innovative approach to health insurance, aiming to simplify the healthcare experience for its members.
Average Trading Volume: 6,833,969
Technical Sentiment Signal: Buy
Current Market Cap: $3.6B
Learn more about OSCR stock on TipRanks’ Stock Analysis page.